"Global pharmaceutical companies are constantly finding new ways to develop innovative drugs despite the recent Covid-19 pandemic."Yoshitake Maeda, the director of Bristol Myers Squibb (BMS)'s business development, search and evaluation for Japan and Asia, explained so during the Seoul International
Vuno, a company specialising in global medical artificial intelligence (AI) solutions, said on Thursday that its AI-based fundus reading solution VUNO Med-Fundus AI has obtained medical device certification from Singapore’s Health Sciences Authority (HSA).Singapore is attracting attention as a bridg
As Covid-19 has continued for years, many domestic medical institutions are dedicating themselves to responding to the pandemic. Myongji Hospital is also one of the institutions that have been actively responding to Covid-19 since the epidemic’s outbreak.One of the common problems facing medical ins
A joint team of Korean researchers discovered that clonal hematopoiesis of indeterminate potential (CHIP), a genetic mutation, was the risk factor for severe Covid-19 patients without underlying diseases. They said they found the molecular mechanisms for the excessive inflammatory response in such C
Celltrion said Wednesday that it obtained a domestic license from the Ministry of Food and Drug Safety (MFDS) for its Avastin biosimilar, Vegzelma (ingredient name: bevacizumab).Consequently, Vegzelma will be able to sell all indications for the drug such as metastatic direct bowel cancer, non-small
TiumBio said on Tuesday that it received a $4.5 million upfront payment from China’s Hansoh Pharmaceutical under the previous licensing agreement involving TU2670, a new endometriosis treatment.Earlier in August, TiumBio and Hansoh signed a $170 million deal, including a $4.5 million upfront payment
Reflecting the continuous decline of new Covid-19 cases, health authorities on Wednesday set the pandemic's risk at a "low level" nationwide, the second-lowest of their five-tier rating system.It was the second time the entire nation entered the low-risk level since the government introduced the wee
Despite Korea's crackdown on the smuggling of capsules from China containing the powdered flesh of dead babies, attempts to smuggle the infant flesh capsules' into Korea are still continuing.According to data by the Korea Customs Service (KCS) submitted to Rep. Kim Young-sun of the ruling People Pow
Mirae Asset Venture Investment and Yuanta Investment have been selected as the management companies of the 500 billion won ($347 million) “K-Bio Vaccine Fund.”The Ministry of Health and Welfare and Korea Venture Investment Corp. (KVIC) on Wednesday announced their final selection of Mirae Asset Vent
Huons Biopharma said it has won product approval for Hutox, its botulinum toxin (BTX) product, in Ecuador.The approval follows the company’s exclusive supply deal with Saludderma, an Ecuador-based aesthetic firm, in May 2020.With the approval, Saludderma plans to launch Hutox in the country by the e
Child abuse cases surged in Korea in the wake of the Covid-19 pandemic apparently affected by reduced outdoor activities, government data showed Wednesday.The worsening data could aggravate Korea’s already ultra-low birth rate because childhood emotional abuse could kill the desire to get married an
All automatic dyeing devices for biopsy introduced by Abbott Korea have become the targets of recall by the Ministry of Food and Drug Safety, it was learned.According to the ministry, the regulator has recently put Abbott Korea’s automatic dyeing device, Alinity h-series, on its list subject to reca
Samsung Bioepis said Tuesday that it would present three scientific abstracts for its ophthalmology biosimilars at the American Academy of Ophthalmology (AAO) 2022 from Sept. 30 to Oct. 3 in the U.S.The company conducted phase 3 studies to compare the efficacy, safety, immunogenicity, and pharmacoki
Ildong Pharmaceutical has requested for changing its previous application for oral Covid-19 treatment candidate substance, Xocova (S-217622).In a public notice Tuesday, Ildong said it had applied to the Ministry of Food and Drug Safety to approve the change in phase 2/3 clinical trial of an investig
A research team at Korea University College of Medicine has developed a wireless chip and smartphone app that can precisely administer drugs to the brains of mice, control their behavior, and monitor brain signals in real-time.The team, led by Professor Cho Il-joo of the Department of Medical Scienc
A report from Statistics Korea showed that 5,030 people died from Covid-19 in 2021, which is five times more than the Covid-19 related deaths in 2020.The Covid-19 death rate per 100,000 people was 9.8, an increase of 7.9 from the previous year's 1.9.By age, the Covid-19 death rate per 100,000 people
"It is quite possible to globalize Korean medicines and medical supplies.”CEO Huh Kyung-hwa of the Korea Innovative Medicines Consortium (KIMCo) affirmed so during a meeting with reporters to commemorate the second anniversary of the consortium’s establishment.KIMCo is a non-profit foundation set up
HLB Therapeutics said that it submitted a clinical protocol to the U.S. FDA on Monday to conduct a second phase 3 clinical trial for a neurotrophic keratitis (NK) treatment through its U.S. subsidiary, ReGenTree.NK is a degenerative disease in which the sensation of the cornea gradually decreases, a
Suicide was the No. 1 cause of South Korean deaths among those aged between 10 and 39, and cancer, among those aged 40 or more, in 2021, government data showed.According to Statistics Korea’s report on the causes of deaths in 2021, an average of 37 people took their lives per day, and the nation’s s
Korean biopharmaceutical companies are turning to rights offering from investors and institutions to raise insufficient funds.A rights offer can help companies raise secondary capital by issuing rights to the company's existing shareholders to buy additional shares in proportion to their existing sh